CON vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

CON

36.0
AI Score
VS
PACS Wins

PACS

54.1
AI Score

Investment Advisor Scores

CON

36score
Recommendation
SELL

PACS

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CON PACS Winner
Revenue 2.85B 1.18B PACS
Net Income 157.06M 115.79M PACS
Net Margin 5.5% 9.8% CON
Operating Income 229.37M 210.68M PACS
ROE 14.1% 24.3% CON
ROA 2.8% 3.8% CON
Total Assets 5.66B 3.01B PACS
Cash 164.45M 158.04M PACS
Current Ratio 0.91 1.38 CON

Relative Price Performance (Last 90 Days)

CON 1M: +11.0% · 3M: +36.8% PACS 1M: -1.3% · 3M: +17.2%

Current Technical Phase

CON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.9% over 20 days), RSI 65

RSI (14): 65.2 · Price: $35.00

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $44.25

Fundamentals Snapshot

Metric CON PACS
Market Cap
Forward P/E 19.1 16.3
Trailing P/E 22.5 25.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.3% 0.2%
Operating Margin 0.2% 0.1%
EPS 1.55 1.71
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.